• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 305_MOSAIC
Device Problem Gradient Increase (1270)
Patient Problem Pulmonary Regurgitation (2023)
Event Date 09/12/2017
Event Type  Injury  
Manufacturer Narrative
Citation: lluri, g.Md et al.Incidence and outcome of infective endocarditis following percutaneous versus surgical pulmonary valve replacement.Catheter cardiovasc interv.(2017) 1-8 doi 10.1002/ccd.27312 earliest date of e-publish/publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information, it cannot be determined whether this event has been previously reported.
 
Event Description
Medtronic received information via literature review regarding the incidence of endocarditis after the implant of a percutaneous pulmonary valve (134) versus a surgical pulmonary valve (208).All data were collected from a single center between 2010 and 2016.The study population included 242 patients, which were implanted with either a medtronic transcatheter pulmonary valve or surgical valve or a non-medtronic transcatheter pulmonary valve or surgical valve.Serial numbers were not provided.The surgical valve study population was predominantly male; mean age 23.3 ± 16.1 years.It was reported that two patients had a previously implanted 23mm hancock or 19mm mosaic.Adverse events among these patients included mild to severe pulmonary regurgitation and increased gradient measurements.The surgical valves were replaced valve-in-valve with a transcatheter pulmonary valve.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key7119243
MDR Text Key94923775
Report Number2025587-2017-02442
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 12/14/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/14/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number305_MOSAIC
Device Catalogue Number305_MOSAIC
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/20/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age23 YR
-
-